{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T03:49:16Z","timestamp":1765338556217,"version":"3.46.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Various serum biomarkers and scoring systems are currently employed to manage septic critically ill patients. However, a paucity of biomarker evidence facilitates sepsis identification or prognosis. Mannose-binding lectin (MBL) is the main circulating protein in innate immunity. It acts as a broad-spectrum recognition molecule that binds most pathogens, along with their breakdown products and cell debris. We report results of an original approach dosing molecular patterns captured by FcMBL, an engineered version of MBL, in patients with septic shock. This study aimed at evaluating molecular patterns kinetics to assess their potential contribution to the clinical management of critically ill patients suffering from septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This monocentric, prospective, observational study was conducted on adults admitted to the intensive care unit (ICU) for septic shock. Using magnetic microbeads coated with FcMBL, we quantified molecular patterns captured in blood and analyzed their kinetics for 5 days. Pathogen-associated molecular patterns (PAMP) levels were sampled at 6-h intervals over the first 24\u00a0h of ICU admission, then at 12\u00a0h intervals on Day 2, and then daily through Day 5. To align the data from the real time of admission to the ICU, the \u201cSerial Measurements\u201d module in MedCalc\n                      <jats:sup>\u00ae<\/jats:sup>\n                      software enabled the incorporation of advanced methods, such as mixed models. Outcomes were the persistence of sepsis after Day 5 and adherence to routine sepsis metrics. Thirty-nine patients were included in the study. At Day 5, 21 patients had recovered from sepsis with a sequential organ failure assessment (SOFA) score\u2009&lt;\u20092, while 18 were not. The initial values of PAMP yielded a median concentration of 5\u00a0ng\/mL. The peak concentration was observed at 9\u00a0ng\/mL, with a median delay of 24\u00a0h. Significant differences were observed in kinetic curves according to the SOFA score at Day 5, with a notable delay in time to peak (Tmax) for the prolonged sepsis group (Hour 48) compared to the short-term sepsis group (Hour 18) (p\u2009&lt;\u20090.001). Compared to standard biomarkers, Tmax PAMP was the most discriminative factor for an unfavorable outcome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Molecular pattern levels captured by FcMBL during septic shock exhibited large inter-patient variability, suggesting values depend on numerous parameters. The signal\u2019s kinetics demonstrated predictive value and may contribute to clinical management.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      : clinicaltrials, NCT03457038, Registered 15 October 2017,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT03457038\" ext-link-type=\"uri\">https:\/\/clinicaltrials.gov\/study\/NCT03457038<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40635-025-00832-x","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T03:44:23Z","timestamp":1765338263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kinetics of molecular patterns captured by mannose-binding lectin in septic shock correlate with clinical outcome: a monocentric prospective observational study"],"prefix":"10.1186","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct03457038","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7132-3816","authenticated-orcid":false,"given":"Alain","family":"Bicart-See","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Vardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marie","family":"Conil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Tudal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Super","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald E.","family":"Ingber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"1","key":"832_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03862-5","volume":"26","author":"T Barichello","year":"2022","unstructured":"Barichello T, Generoso JS, Singer M, Dal-Pizzol F (2022) Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review. Crit Care 26(1):14. https:\/\/doi.org\/10.1186\/s13054-021-03862-5","journal-title":"Crit Care"},{"issue":"3","key":"832_CR2","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1097\/CCM.0000000000006560","volume":"53","author":"T Zimmermann","year":"2025","unstructured":"Zimmermann T, Brealey D, Singer M (2025) The search for sepsis biomarkers: a tale of promises, pitfalls, and potential. Crit Care Med 53(3):e543\u2013e547. https:\/\/doi.org\/10.1097\/CCM.0000000000006560","journal-title":"Crit Care Med"},{"key":"832_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"832_CR4","doi-asserted-by":"publisher","unstructured":"Silva-Gomes S., Decout A., Nigou J. (2014) Pathogen-Associated Molecular Patterns (PAMPs). In: Parnham M. (eds) Encyclopedia of Inflammatory Diseases. Birkh\u00e4user, Basel. https:\/\/doi.org\/10.1007\/978-3-0348-0620-6_35-1.","DOI":"10.1007\/978-3-0348-0620-6_35-1"},{"issue":"25","key":"832_CR5","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.17447.1","volume":"8","author":"BT Seiler","year":"2019","unstructured":"Seiler BT, Cartwright M, Dinis ALM, Duffy S, Lombardo P, Cartwright D, Super EH, Lanzaro J, Dugas K, Super M, Ingber DE (2019) Broad-spectrum capture of clinical pathogens using engineered Fc-mannose-binding lectin enhanced by antibiotic treatment. F1000Res 8(25):108. https:\/\/doi.org\/10.12688\/f1000research.17447.1","journal-title":"F1000Res"},{"issue":"12","key":"832_CR6","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1007\/s00134-016-4544-8","volume":"42","author":"K Asehnoune","year":"2016","unstructured":"Asehnoune K, Villadangos J, Hotchkiss RS (2016) Understanding host-pathogen interaction. Intensive Care Med 42(12):2084\u20132086. https:\/\/doi.org\/10.1007\/s00134-016-4544-8","journal-title":"Intensive Care Med"},{"issue":"2","key":"832_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/sur.2017.264","volume":"19","author":"A Rajaee","year":"2018","unstructured":"Rajaee A, Barnett R, Cheadle WG (2018) Pathogen- and Danger-Associated Molecular Patterns and the Cytokine Response in Sepsis. Surg Infect (Larchmt) 19(2):107\u2013116. https:\/\/doi.org\/10.1089\/sur.2017.264","journal-title":"Surg Infect (Larchmt)"},{"issue":"10","key":"832_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nm.3640","volume":"20","author":"JH Kang","year":"2014","unstructured":"Kang JH, Super M, Yung CW, Cooper RM, Domansky K, Graveline AR, Mammoto T, Berthet JB, Tobin H, Cartwright MJ, Watters AL, Rottman M, Waterhouse A, Mammoto A, Gamini N, Rodas MJ, Kole A, Jiang A, Valentin TM, Diaz A, Takahashi K, Ingber DE (2014) An extracorporeal blood-cleansing device for sepsis therapy. Nat Med 20(10):1211\u20131216. https:\/\/doi.org\/10.1038\/nm.3640","journal-title":"Nat Med"},{"key":"832_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ebiom.2016.06.014","volume":"9","author":"M Cartwright","year":"2016","unstructured":"Cartwright M, Rottman M, Shapiro NI, Seiler B, Lombardo P, Gamini N, Tomolonis J, Watters AL, Waterhouse A, Leslie D, Bolgen D, Graveline A, Kang JH, Didar T, Dimitrakakis N, Cartwright D, Super M, Ingber DE (2016) A broad-spectrum infection diagnostic that detects Pathogen-Associated Molecular Patterns (PAMPs) in whole blood. EBioMedicine 9:217\u2013227. https:\/\/doi.org\/10.1016\/j.ebiom.2016.06.014","journal-title":"EBioMedicine"},{"issue":"2","key":"832_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/jama.2021.23916","volume":"327","author":"DC Angus","year":"2022","unstructured":"Angus DC, Bindman AB (2022) Achieving diagnostic excellence for sepsis. JAMA 327(2):117\u2013118. https:\/\/doi.org\/10.1001\/jama.2021.23916","journal-title":"JAMA"},{"issue":"2","key":"832_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020962","volume":"25","author":"S Cicchinelli","year":"2024","unstructured":"Cicchinelli S, Pignataro G, Gemma S, Piccioni A, Picozzi D, Ojetti V, Franceschi F, Candelli M (2024) PAMPs and DAMPs in sepsis: a review of their molecular features and potential clinical implications. Int J Mol Sci 25(2):962. https:\/\/doi.org\/10.3390\/ijms25020962","journal-title":"Int J Mol Sci"},{"issue":"23","key":"832_CR12","doi-asserted-by":"publisher","first-page":"S300","DOI":"10.1093\/ofid\/ofz360.721","volume":"6","author":"KS Akers","year":"2019","unstructured":"Akers KS, Schlotman T, Mangum LC, Garcia G, Wagner A, Seiler B, Cartwright M, Rifai S, Ingber D, Super M (2019) 653. Diagnosis of burn sepsis using the FcMBL ELISA: a pilot study in critically ill burn patients. Open Forum Infect Dis 6(23):S300. https:\/\/doi.org\/10.1093\/ofid\/ofz360.721","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"832_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jinf.2020.01.010","volume":"80","author":"CB Hansen","year":"2020","unstructured":"Hansen CB, Bayarri-Olmos R, Kristensen MK, Pilely K, Hellemann D, Garred P (2020) Complement related pattern recognition molecules as markers of short-term mortality in intensive care patients. J Infect 80(4):378\u2013387. https:\/\/doi.org\/10.1016\/j.jinf.2020.01.010","journal-title":"J Infect"},{"issue":"3","key":"832_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1164\/rccm.201910-1911TR","volume":"202","author":"J Joffre","year":"2020","unstructured":"Joffre J, Hellman J, Ince C, Ait-Oufella H (2020) Endothelial responses in sepsis. Am J Respir Crit Care Med 202(3):361\u2013370. https:\/\/doi.org\/10.1164\/rccm.201910-1911TR","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"832_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/SHK.0b013e3182903f0d","volume":"39","author":"S Skibsted","year":"2013","unstructured":"Skibsted S, Jones AE, Puskarich MA, Arnold R, Sherwin R, Trzeciak S, Schuetz P, Aird WC, Shapiro NI (2013) Biomarkers of endothelial cell activation in early sepsis. Shock 39(5):427\u2013432. https:\/\/doi.org\/10.1097\/SHK.0b013e3182903f0d","journal-title":"Shock"},{"key":"832_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.biomaterials.2015.07.046","volume":"67","author":"TF Didar","year":"2015","unstructured":"Didar TF, Cartwright MJ, Rottman M, Graveline AR, Gamini N, Watters AL, Leslie DC, Mammoto T, Rodas MJ, Kang JH, Waterhouse A, Seiler BT, Lombardo P, Qendro EI, Super M, Ingber DE (2015) Improved treatment of systemic blood infections using antibiotics with extracorporeal opsonin hemoadsorption. Biomaterials 67:382\u2013392. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.07.046","journal-title":"Biomaterials"},{"key":"832_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41551-021-00756-3","volume":"6","author":"M Super","year":"2022","unstructured":"Super M, Doherty EJ, Cartwright MJ et al (2022) Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock. Nat Biomed Eng 6:8\u201318. https:\/\/doi.org\/10.1038\/s41551-021-00756-3","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"832_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2021.122472","volume":"233","author":"Y Xue","year":"2021","unstructured":"Xue Y, Shi H, Feng B, Qiao L, Ding C, Yu S (2021) Rapid identification of bacteria directly from blood cultures by co-magnetic bead enrichment and MALDI-TOF MS profiling. Talanta 233(1):122472. https:\/\/doi.org\/10.1016\/j.talanta.2021.122472","journal-title":"Talanta"},{"issue":"11","key":"832_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0276777","volume":"17","author":"KA Kite","year":"2022","unstructured":"Kite KA, Loomba S, Elliott TJ, Yongblah F, Lightbown SL, Doyle TJ, Gates L, Alber D, Downey GA, McCurdy MT, Hill JA, Super M, Ingber DE, Klein N, Cloutman-Green E (2022) FcMBL magnetic bead-based MALDI-TOF MS rapidly identifies paediatric blood stream infections from positive blood cultures. PLoS ONE 17(11):e0276777. https:\/\/doi.org\/10.1371\/journal.pone.0276777","journal-title":"PLoS ONE"},{"issue":"1","key":"832_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74868-6","volume":"14","author":"H Alpkvist","year":"2024","unstructured":"Alpkvist H, Ziegler I, M\u00f6lling P, Tina E, Sellv\u00e9n L, Norrby-Teglund A, Cajander S, Str\u00e5lin K (2024) Damage-associated molecular patterns in bacteraemic infection, including a comparative analysis with bacterial DNA, a pathogen-associated molecular pattern. Sci Rep 14(1):23499. https:\/\/doi.org\/10.1038\/s41598-024-74868-6","journal-title":"Sci Rep"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00832-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-025-00832-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00832-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T03:44:24Z","timestamp":1765338264000},"score":1,"resource":{"primary":{"URL":"https:\/\/icm-experimental.springeropen.com\/articles\/10.1186\/s40635-025-00832-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1186\/s40635-025-00832-x","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Formal ethical approval was obtained by the institutional review board \"Comite de Protection des Personnes Sud-Est I\" (RC31\/17\/0157). Informed consent was obtained for all patients included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ABS, FV, SR, JMC, VT, MS, DEI, EO have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}